AL-611

· Alios Biopharma Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AL-611, covering 2017-10-25 to 2017-10-25. Get the full timeline:

Most recent: Clinical Trial Update: A First in Human Study of AL-611 in Healthy Volunteers and Patients With Hepatitis C Virus Infection [Phase 1]